Introduction
Women's
Health and the Environment in the 21st Century
Kenneth Olden and Retha R. Newbold
p. 767
Overview, Summary, and Future Research Recommendations
Advances
in Uterine Leiomyoma Research: Conference Overview, Summary, and Future
Research Recommendations
Retha R. Newbold, Richard P. DiAugustine, John I. Risinger, Jeffrey
I. Everitt, David K. Walmer, Estella C. Parrott, and Darlene Dixon
p. 769
Biology and Histopathology of the Uterus
Genetic
Approaches to the Study of Uterine Leiomyomata
Cynthia C. Morton
p. 775
Pathology
and Pathophysiology of Uterine Smooth-Muscle Tumors
Stanley J. Robboy, Rex C. Bentley, Kelly Butnor, and Malcolm C. Anderson
p. 779
Mechanisms of Tumor Development: Hormones and Growth Factors
Regulation
of Vascular Endothelial Growth Factor Expression by Estrogens and Progestins
Salman M. Hyder, Jaou-Chen Huang, Zafar Nawaz, Holly Boettger-Tong,
Sari Mäkelä, Connie Chiappetta, and George M. Stancel
p. 785
Advances
in Uterine Leiomyoma Research: The Progesterone Hypothesis
Mitchell S. Rein
p. 791
Immunohistochemical
Localization of Growth Factors and Their Receptors in Uterine Leiomyomas
and Matched Myometrium
Darlene Dixon, Hong He, and Joseph K. Haseman
p. 795
Mechanisms of Tumor Development: Molecular Alterations
Structure
and Function of the HMGI(Y) Family of Architectural Transcription Factors
Raymond Reeves
p. 803
Comparing
Regulation of the connexin43 Gene by Estrogen in Uterine Leiomyoma
and Pregnancy Myometrium
Janet Andersen
p. 811
Pregnancy,
Parturition, and Prostaglandins: Defining Uterine Leiomyomas
Kimberley Cesen-Cummings, John A. Copland, J. Carl Barrett, Cheryl L.
Walker, and Barbara J. Davis
p. 817
Epidemiology and Environmental Influences
Epidemiologic
Contributions to Understanding the Etiology of Uterine Leiomyomata
Stephen M. Schwartz, Lynn M. Marshall, and Donna D. Baird
p. 821
Transnational Research and Experimental Model Systems
Influence
of Exogenous Estrogen Receptor Ligands on Uterine Leiomyoma: Evidence
from an in Vitro/in Vivo Animal Model for Uterine Fibroids
Deborah S. Hunter, Leslie C. Hodges, Patricia K. Eagon, Peter M. Vonier,
Robin Fuchs-Young, Jill S. Bergerson, and Cheryl L. Walker
p. 829
Clinical Experience and Therapeutics
Clinical
Decision Making Regarding Leiomyomata: What We Need in the Next Millenium
A. F. Haney
p. 835
Review
of the Evidence for Treatment of Leiomyomata
David L. Olive
p. 841
Impact
of Uterine Fibroids on ART Outcome
David L. Healy
p. 845
Novel
Therapeutic Strategies for Leiomyomas: Targeting Growth Factors and
Their Receptors
Romana A. Nowak
p. 849
